Is This the New Playbook for Curing Rare Childhood Diseases? | MIT Sloan
“There is no treatment available for your son. We can’t do anything to help him.”
When Fernando Goldsztein, SF ’03, heard those words, something inside him snapped.“I refused to accept what the doctors were saying. I transformed my fear into my greatest strength and started fighting.”Goldsztein’s 12-year-old son Frederico was diagnosed with relapsing medulloblastoma, a life-threatening pediatric brain tumor. His life—and career plan—changed in an instant.
He had to learn to become a different kind of leader altogether.